{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:33:46Z","timestamp":1794018826543,"version":"4.8.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":150,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018-12367572"],"award-info":[{"award-number":["GR-2018-12367572"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.diagmicrobio.2024.116372","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T06:52:04Z","timestamp":1716274324000},"page":"116372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["In vivo emergence of cefiderocol and ceftazidime\/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime\/avibactam -based therapies"],"prefix":"10.1016","volume":"110","author":[{"given":"Stefano","family":"Amadesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Amedeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Palombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3791-8635","authenticated-orcid":false,"given":"Paolo","family":"Gaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116372_bib0001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cll.2017.01.005","article-title":"Carbapenem-Resistant Enterobacteriaceae","volume":"37","author":"Iovleva","year":"2017","journal-title":"Clin Lab Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116372_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: A siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2024.116372_bib0003","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jgar.2022.06.021","article-title":"Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime\/avibactam, meropenem\/vaborbactam, imipenem\/relebactam and cefiderocol isolated from a critically ill patient","volume":"30","author":"Gaibani","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116372_bib0004","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cmi.2021.04.016","article-title":"Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC \u03b2-lactamase mutants and the inoculum effect","volume":"27","author":"Hobson","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116372_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01108-23","article-title":"The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate","volume":"68","author":"Birgy","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116372_bib0006","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciab511","article-title":"Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA","volume":"74","author":"Klein","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116372_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10096-021-04341-z","article-title":"In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects","volume":"41","author":"Bianco","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116372_bib0008","doi-asserted-by":"crossref","first-page":"e00951","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol Antimicrobial Susceptibility testing considerations: the Achilles' heel of the trojan horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116372_bib0009","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/jac\/dkac100","article-title":"Dynamic evolution of imipenem\/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime\/avibactam-based treatments","volume":"77","author":"Gaibani","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116372_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00574-21","article-title":"Evolutionary trajectories toward ceftazidime-avibactam resistance in klebsiella pneumoniae clinical isolates","volume":"65","author":"Carattoli","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116372_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01600-22","article-title":"Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee Advisory","volume":"61","author":"Simner","year":"2023","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324002013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324002013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T20:12:52Z","timestamp":1740341572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324002013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0732889324002013"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116372","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo emergence of cefiderocol and ceftazidime\/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime\/avibactam -based therapies","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116372"}}